glp-1 adoption US households with users cut their grocery spending When millions of consumers change

Specifically, protein S deficiency, protein C deficiency, activated protein c resistance, antithrombin deficiency and dysfibrinogenemia (11)

Sales of functional drinks are already rising and can be propelled by GLP-1 usage

Researchers studied 47,199 patients with cardiovascular disease who received Novo Nordisk's GLP-1 drug semaglutide, sold as Ozempic for diabetes and Wegovy for obesity, for up to two years

Every athlete, from the fitness enthusiast to the professional, is on a journey to improve every day

The next stage will focus on diagnosing the biological drivers of obesity and matching patients to the right combination of medications, behavioral support, and possibly advanced therapies